Medicare Enrolled
Dr. Steven Hager, D.O.
Hematology & Oncology · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hager from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hager?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hager
Dr. Steven Hager is a hematology & oncology specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hager performed 320,590 Medicare services across 6,726 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hager received a total of $108,993 from 71 pharmaceutical and/or device companies across 622 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hager is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in CA
$108,993 industry payments
Medicare Practice Summary
Medicare Utilization ↗320,590
Medicare services
Top 1% in CA for hematology & oncology
6,726
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16,873 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
83,200 | $2 | $12 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
73,500 | $1 | $9 |
| Nivolumab injection (Opdivo) | 29,260 | $24 | $72 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
16,400 | $0 | $9 |
| Denosumab injection (Prolia/Xgeva) | 16,080 | $18 | $51 |
| Paclitaxel chemotherapy injection | 11,628 | $0 | $8 |
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
10,350 | $0 | $8 |
| Anti-nausea injection (aprepitant) | 8,450 | $1 | $11 |
| Pembrolizumab injection (Keytruda) | 8,400 | $43 | $127 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,800 | $0 | $1 |
| Bevacizumab-maly biosimilar injection, 10 mg An injection of bevacizumab-maly, a biosimilar medication, with a dosage of 10 mg. |
5,500 | $57 | $185 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
5,020 | $36 | $118 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
5,016 | $26 | $88 |
| Injection, granisetron, extended-release, 0.1 mg | 5,000 | $5 | $20 |
| Injection, durvalumab, 10 mg | 4,262 | $62 | $193 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,012 | $0 | $8 |
| Iron infusion (Monoferric) | 3,000 | $16 | $62 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
2,730 | $26 | $149 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,337 | $8 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,217 | $8 | $11 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
1,860 | $34 | $225 |
| Rituximab-arrx biosimilar injection, 10 mg An injection of rituximab-arrx, a biosimilar medication, administered in a 10 mg dose. |
1,740 | $35 | $185 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,336 | $10 | $27 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,270 | $1 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,120 | $100 | $418 |
| Injection, fulvestrant, 25 mg | 1,100 | $8 | $51 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
830 | $11 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
721 | $66 | $286 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
575 | $24 | $87 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
544 | $111 | $400 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 393 | $3 | $14 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
387 | $2 | $12 |
| Iron level test | 374 | $6 | $17 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
374 | $9 | $22 |
| Injection, leucovorin calcium, per 50 mg | 351 | $3 | $13 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
347 | $64 | $188 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
336 | $1 | $6 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
317 | $52 | $197 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
266 | $1 | $9 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
217 | $2 | $10 |
| Pegfilgrastim-fpgk biosimilar injection, 0.5 mg An injection of pegfilgrastim-fpgk, a biosimilar medication, administered at a dose of 0.5 mg. |
204 | $274 | $853 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
203 | $144 | $558 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
194 | $24 | $84 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
187 | $1 | $10 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
167 | $55 | $195 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
162 | $61 | $222 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
157 | $13 | $35 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
155 | $13 | $47 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
147 | $28 | $90 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
140 | $6 | $16 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
132 | $17 | $61 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 129 | $285 | $898 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
122 | $3 | $9 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
122 | $4 | $11 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
121 | $1,361 | $4,921 |
| Injection, alteplase recombinant, 1 mg | 117 | $67 | $220 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
116 | $9 | $24 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
109 | $15 | $38 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
95 | $4 | $10 |
| PSA test (prostate cancer screening) | 93 | $18 | $46 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 72 | $20 | $53 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
66 | $1 | $9 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 64 | $20 | $53 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
60 | $27 | $94 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
59 | $16 | $42 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
58 | $109 | $450 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
56 | $27 | $155 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
52 | $49 | $145 |
| Electrophoresis laboratory test A laboratory testing technique that separates molecules based on their size and electrical charge. |
47 | $60 | $154 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
47 | $4 | $14 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
45 | $110 | $410 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
43 | $19 | $48 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
42 | $12 | $32 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
40 | $8 | $22 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
32 | $4 | $11 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
30 | $94 | $252 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
27 | $254 | $943 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
27 | $50 | $248 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
26 | $116 | $628 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
26 | $3,604 | $9,900 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
25 | $7 | $17 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
24 | $17 | $58 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
24 | $78 | $303 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
21 | $25 | $65 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
20 | $4 | $12 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $140 | $508 |
| New patient office visit, complex (60-74 min) | 19 | $176 | $594 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
13 | $100 | $480 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
13 | $78 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.6% high complexity
69.9% medium
3.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$108,993
Total received (2018-2024)
Avg $15,570/year across 7 years
Top 8% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
622
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$70,829 (65.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$30,733 (28.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,431 (6.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,290
2023
$28,707
2022
$7,949
2021
$20,631
2020
$14,655
2019
$8,215
2018
$20,546
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,992
E.R. Squibb & Sons, L.L.C.
$2,405
Celgene Corporation
$369
GlaxoSmithKline, LLC.
$161
Exelixis Inc.
$157
Novartis Pharmaceuticals Corporation
$156
Daiichi Sankyo Inc.
$145
Agios Pharmaceuticals, Inc.
$137
ABBVIE INC.
$136
PFIZER INC.
$85
SpringWorks Therapeutics, Inc.
$81
Ipsen Biopharmaceuticals, Inc
$80
Lilly USA, LLC
$54
Takeda Pharmaceuticals U.S.A., Inc.
$38
BeiGene USA, Inc.
$36
Sirtex Medical Inc
$35
PharmaEssentia USA Corporation
$33
Pharmacosmos Therapeutics Inc.
$30
Merck Sharp & Dohme LLC
$26
Eisai Inc.
$25
TAIHO ONCOLOGY, INC.
$23
Janssen Biotech, Inc.
$20
Gilead Sciences, Inc.
$19
Astellas Pharma US Inc
$19
SERVIER PHARMACEUTICALS LLC
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 81.6% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$16,475
AstraZeneca Pharmaceuticals LP
$14,665
Seagen Inc.
$8,827
Gilead Sciences, Inc.
$8,701
Cornerstone Specialty Network LLC
$8,180
Epizyme, Inc.,
$7,345
Exelixis Inc.
$6,944
E.R. Squibb & Sons, L.L.C.
$6,745
Karyopharm Therapeutics Inc.
$3,874
Kite Pharma, Inc.
$3,243
Shield Therapeutics Inc
$3,201
Puma Biotechnology, Inc.
$2,881
Celgene Corporation
$2,477
ARRAY BIOPHARMA INC
$2,400
Amgen Inc.
$2,313
GlaxoSmithKline, LLC.
$1,856
PFIZER INC.
$1,732
MorphoSys, US Inc.
$1,457
Alexion Pharmaceuticals, Inc.
$492
Novartis Pharmaceuticals Corporation
$436
Incyte Corporation
$351
Astellas Pharma US Inc
$260
Lilly USA, LLC
$251
Novocure GmbH
$250
Genentech USA, Inc.
$235
Pharmacyclics LLC, An AbbVie Company
$206
Sirtex Medical Inc
$192
Octapharma USA, Inc.
$178
Athenex Pharmaceutical Division, LLC
$175
Regeneron Healthcare Solutions, Inc.
$167
ABBVIE INC.
$160
Cardinal Health 108, LLC
$152
Ipsen Biopharmaceuticals, Inc
$150
Takeda Pharmaceuticals U.S.A., Inc.
$142
Agios Pharmaceuticals, Inc.
$137
Foundation Medicine, Inc.
$113
Seattle Genetics, Inc.
$109
BeiGene USA, Inc.
$102
COMSORT, Inc
$100
Spectrum Pharmaceuticals Inc.
$95
Janssen Biotech, Inc.
$90
SpringWorks Therapeutics, Inc.
$81
Merck Sharp & Dohme LLC
$80
Pharmacyclics LLC, an AbbVie Company
$70
PharmaEssentia USA Corporation
$69
GENZYME CORPORATION
$64
SOBI, INC
$64
Merck Sharp & Dohme Corporation
$63
Coherus Biosciences Inc.
$62
Sobi, Inc
$60
Myovant Sciences Inc.
$59
EMD Serono, Inc.
$53
TerSera Therapeutics LLC
$42
Eisai Inc.
$37
Bayer HealthCare Pharmaceuticals Inc.
$33
Pharmacosmos Therapeutics Inc.
$30
EISAI INC.
$29
AbbVie Inc.
$28
ImmunoGen, Inc.
$24
TAIHO ONCOLOGY, INC.
$23
Genmab U.S., Inc.
$19
Dova Pharmaceuticals
$18
Stemline Therapeutics Inc.
$16
Acrotech Biopharma LLC
$16
PUMA BIOTECHNOLOGY, INC.
$15
Myriad Genetic Laboratories, Inc.
$14
Deciphera Pharmaceuticals Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
AbbVie, Inc.
$12
TESARO, Inc.
$12
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · ALIMTA · ALUNBRIG · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · CREON · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · Elahere · Enhertu · Epkinly · FIBRYGA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · NUWIQ · Nerlynx · Nplate · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · Revlimid · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Soliris · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · Tazverik · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Yescarta · ZEJULA · Zevalin · Zydelig · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (65%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for hematology & oncology in CA.
Geographic Context
Hematology & oncology specialists within 10 mi
28
Per 100K population
2.8
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hager is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with consulting-driven industry engagement in the top 8% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hager experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Hager performed 83,200 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hager receive payments from pharmaceutical companies?
Yes. Dr. Hager received a total of $108,993 from 71 companies across 622 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hager's costs compare to other hematology & oncology specialists in Fresno?
Dr. Hager's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hager) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fresno
Browse hematology & oncology specialists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology